Print    Email
Decrease (-) Restore Default Increase (+)

Clinical Trials

Treatment   Allergy and Immunology
Trial Title   A Randomized, Double-Blind, Placebo-Controlled Parallel Group Efficacy & Safety Trial of Sublingual-Oral Immunotherapy (SLIT) in Adults With Allergic Rhinoconjunctivitis Caused by Ragweed Pollen
Description of Research   The purpose of this study is to find out if an investigational therapy containing a known amount of Ragweed Allergenic Extract is effective in reducing symptoms of rhinoconjunctivitis.
Study Number   HSR-11-1208
Inclusion/Notes   Participants have allergic rhinoconjunctivitis upon exposure to ragweed. This means that you have symptoms such as sneezing, and a runny, stuffy or itchy nose as well as itchy, watery and red eyes during ragweed season.
Principal Investigator   Jeffrey G. Leflein, M.D.
Contact Name   Patricia Lezak, CCRC
Phone   (734) 528-0477
A Member of Trinity Health
© 2015 Trinity Health

St. Joseph Mercy Ann Arbor | 5301 McAuley Drive, Ypsilanti, MI 48197 | 734-712-3456